Growth Hormone Decline & Aging

Growth hormone (GH) production declines approximately 14% per decade after age 30 — a process called somatopause. By age 60, most adults produce less than half the GH they did at 25. This decline is associated with increased body fat, decreased muscle mass, thinner skin, poorer sleep, slower recovery, and reduced bone density.

The CJC-1295 + Ipamorelin Approach

The Midas Protocol uses CJC-1295 No DAC (GHRH analog) paired with Ipamorelin (the most selective ghrelin mimetic) to restore natural pulsatile GH release. This is gentler than exogenous HGH — it works with the body's existing GH axis rather than replacing it, preserving natural feedback regulation.